Acarix AB (SE:ACARIX)
:ACARIX
Want to see SE:ACARIX full AI Analyst Report?
ACARIX Stock Chart & Stats
kr0.28
>-kr0.01(-3.04%)
At close: 4:00 PM EST
kr0.28
>-kr0.01(-3.04%)
Day’s Range― - ―
52-Week Rangekr0.22 - kr0.47
Previous CloseN/A
Volume265.37K
Average Volume (3M)1.57M
Market Cap
kr299.93M
Enterprise Valuekr279.75M
Total Cash (Recent Filing)kr25.79M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.21
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding1,123,320,200
10 Day Avg. Volume1,780,482
30 Day Avg. Volume1,572,056
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)7.91
Price to Sales (P/S)41.02
P/FCF Ratio-6.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)kr19.80M
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetAn essentially debt-free balance sheet materially lowers refinancing and interest-rate risk and preserves flexibility. This conservative financing gives management room to fund commercialization or bridge capital needs without immediate leverage, supporting durable optionality for scaling.
Gross Margin ImprovementA material rise in gross margin signals improving unit economics for the CADScor system. Sustained higher margins increase operating leverage as sales scale, making profitable outcomes feasible at lower revenue thresholds and improving long-term cash conversion as adoption expands.
Recurring Revenue PotentialThe business model combines hardware sales with recurring consumables and service revenue, creating predictable, high-frequency revenue streams. As installed base grows, recurring items support revenue stability, higher lifetime value and more reliable cash flows versus one-time hardware sales.
Bears Say
High Cash BurnLarge negative operating and free cash flow indicate persistent cash burn and ongoing financing needs. This creates material execution risk: the company must secure additional capital or quickly improve cash generation, or face dilution, constrained investments, and pressure on commercialization plans.
Deep Operating LossesExtremely negative margins and sustained operating losses undermine return metrics and limit internal funding capacity. Even with revenue growth, continued heavy losses require meaningful and sustained improvement in scale or mix before the business can achieve durable profitability.
Eroding Equity / Negative ROEPersistent losses have eroded the equity base and produced deeply negative ROE, reducing the firm’s capital cushion. A weakened equity position heightens vulnerability to funding shocks and raises the likelihood of dilutive raises, limiting long-term strategic flexibility.
Acarix AB News
ACARIX FAQ
What was Acarix AB’s price range in the past 12 months?
Acarix AB lowest stock price was kr0.22 and its highest was kr0.47 in the past 12 months.
What is Acarix AB’s market cap?
Acarix AB’s market cap is kr299.93M.
When is Acarix AB’s upcoming earnings report date?
Acarix AB’s upcoming earnings report date is Aug 13, 2026 which is in 82 days.
How were Acarix AB’s earnings last quarter?
Acarix AB released its earnings results on May 18, 2026. The company reported -kr0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.008.
Is Acarix AB overvalued?
According to Wall Street analysts Acarix AB’s price is currently Overvalued.
Does Acarix AB pay dividends?
Acarix AB does not currently pay dividends.
What is Acarix AB’s EPS estimate?
Acarix AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acarix AB have?
Acarix AB has 1,123,320,200 shares outstanding.
What happened to Acarix AB’s price movement after its last earnings report?
Acarix AB reported an EPS of -kr0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.386%.
Which hedge fund is a major shareholder of Acarix AB?
Currently, no hedge funds are holding shares in SE:ACARIX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Acarix AB
Acarix AB (publ), a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases in Germany, Sweden, the Middle East, Switzerland, Austria, and internationally. The company offers CADScor System, a non-invasive and ultra-sensitive analytical device for the diagnosis of coronary artery disease. Acarix AB (publ) was founded in 2009 and is headquartered in Malmö, Sweden.